James H. Mackaness, CHIEF FINANCIAL OFFICER at SOLENO THERAPEUTICS INC (SLNO), sold 15,427 shares at $46.18 ($706K) on 2025-01-03, disclosed to the SEC on 2025-01-06.
Open-market sale of $706k SLNO by CHIEF FINANCIAL OFFICER. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $45.37 | 3,762 | $171K | 24.2% |
| 2 | $45.37 | 3,762 | $171K | 24.2% |
| 3 | $45.92 | 321 | $15K | 2.1% |
| 4 | $46.18 | 3,791 | $175K | 24.8% |
| 5 | $46.18 | 3,791 | $175K | 24.8% |
| Total | $45.78 avg | 15,427 |
| $706K |
| 100% |
| Filing → |
| SLNO | SELL | 2024-08-30 | $1.1M | — | Filing → |
| SLNO | SELL | 2024-08-07 | $1.3M | — | Filing → |
| SLNO | SELL | 2024-07-03 | $597K | — | Filing → |